GRDX (GridAI Technologies) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GRDX GridAI Technologies Corp GRDX
26 GF Score
Price $3.99
! 2 Warning Signs
View Full Analysis

What is GridAI Technologies Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

GRDX vs CELU, NRSN, ZIVO: Short Interest Comparison

For the Biotechnology subindustry, GridAI Technologies's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GridAI Technologies Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GridAI Technologies's Short Interest distribution charts can be found below:

* The bar in red indicates where GridAI Technologies's Short Interest falls into.


GRDX
26GF Score
GridAI Technologies Corp GRDX
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GridAI Technologies Business Description

Address 433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
26GF Score

Get the complete analysis for GRDX

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.99
Price